Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Mifepristone, Title X and abortion access surface in confirmation hearing; nominee says he will follow president's policies
Summary
Abortion policy and regulation of the medication mifepristone were major topics Thursday as senators pressed Robert F. Kennedy Jr. on whether he would use HHS authority to restrict access if confirmed as secretary of Health and Human Services.
Abortion policy and regulation of the medication mifepristone were recurring subjects at the Senate Finance Committee hearing for Robert F. Kennedy Jr., reflecting senators’ concerns about whether the nominee would use HHS authority to restrict access.
Sen. Ron Wyden asked whether Kennedy would “abuse his power as our country's chief health officer to essentially implement a national abortion ban by restricting access to the safe and legal medication” mifepristone. Kennedy said he would study the drug’s safety at the direction of the president and that President Trump had asked him to "look at safety issues" related to mifepristone; he said the president had not given him a final policy direction.
T…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
